Attenuation of Experimental Atherosclerosis by Interleukin-19

OBJECTIVE: Interleukin-19 (IL-19) is putative Th2, anti-inflammatory interleukin. Its expression in, and potential role in atherogenesis is unknown. IL-19 is not detected in normal artery, and is expressed to a greater degree in plaque from symptomatic vs. asymptomatic patients, suggesting a compens...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Ellison, Stephen, Gabunia, Khatuna, Kelemen, Sheri E., England, Ross N., Scalia, Rosario, Richards, James M., Orr, Wayne, Traylor, James G., Rogers, Thomas, Cornwell, William, Berglund, Lisa M., Goncalves, Isabel, Gomez, Maria F., Autieri, Michael V.
Formato: Artigo
Idioma:Inglês
Publicado: 2013
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3950941/
https://ncbi.nlm.nih.gov/pubmed/23950143
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/ATVBAHA.113.301521
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares